These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20046014)

  • 1. [Novel animal models for bullous pemphigoid utilized by "humanization of autoantigen"].
    Nishie W; Shimizu H
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):472-7. PubMed ID: 20046014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
    Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
    J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
    Nishie W
    Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.
    Wada M; Nishie W; Ujiie H; Izumi K; Iwata H; Natsuga K; Nakamura H; Kitagawa Y; Shimizu H
    J Invest Dermatol; 2016 May; 136(5):938-946. PubMed ID: 26827765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.
    Natsuga K; Nishie W; Shinkuma S; Ujiie H; Nishimura M; Sawamura D; Shimizu H
    J Immunol; 2012 Jun; 188(11):5792-9. PubMed ID: 22523387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.
    Nishie W; Sawamura D; Natsuga K; Shinkuma S; Goto M; Shibaki A; Ujiie H; Olasz E; Yancey KB; Shimizu H
    J Immunol; 2009 Sep; 183(6):4088-93. PubMed ID: 19717520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models.
    Ujiie H; Yoshimoto N; Natsuga K; Muramatsu K; Iwata H; Nishie W; Shimizu H
    Front Immunol; 2019; 10():1410. PubMed ID: 31275329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of autoantigen.
    Nishie W; Sawamura D; Goto M; Ito K; Shibaki A; McMillan JR; Sakai K; Nakamura H; Olasz E; Yancey KB; Akiyama M; Shimizu H
    Nat Med; 2007 Mar; 13(3):378-83. PubMed ID: 17322897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
    Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
    J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.
    Kamaguchi M; Iwata H; Ujiie H; Natsuga K; Nishie W; Kitagawa Y; Shimizu H
    J Invest Dermatol; 2018 Aug; 138(8):1707-1715. PubMed ID: 29530535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of bullous pemphigoid.
    Ujiie H; Nishie W; Shimizu H
    Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
    Nishie W; Natsuga K; Iwata H; Izumi K; Ujiie H; Toyonaga E; Hata H; Nakamura H; Shimizu H
    Am J Pathol; 2015 May; 185(5):1361-71. PubMed ID: 25773176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?
    Ujiie H
    J Dermatol Sci; 2015 Apr; 78(1):5-10. PubMed ID: 25797172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
    Nishie W
    J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's new in bullous pemphigoid.
    Ujiie H; Shibaki A; Nishie W; Shimizu H
    J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
    Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
    Front Immunol; 2018; 9():488. PubMed ID: 29599777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.
    Pigors M; Patzelt S; Reichhelm N; Dworschak J; Khil'chenko S; Emtenani S; Bieber K; Hofrichter M; Kamaguchi M; Goletz S; Köhl G; Köhl J; Komorowski L; Probst C; Vanderheyden K; Balbino B; Ludwig RJ; Verheesen P; Schmidt E
    J Pathol; 2024 Feb; 262(2):161-174. PubMed ID: 37929639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.